EU approves life changing ‘important’ Alzheimer’s drug which can drastically slow onset  

   Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of efficacy in slowing progression of the disease, says gov.uk Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of efficacy in slowing progression of the disease, says gov.uk Nottinghamshire Live – NewsRead More